Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Kwang Woo Ahn et al.|Transplantation and Cellular Therapy|2018Cited by 44
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution ExperienceMorris Kletzel, Sana Khan, Kyle Kauffman et al.|Transplantation and Cellular Therapy|2015Cited by 0
Does Partial Donor Chimerism (PDC) Increase the Risk of Relapse in Pediatric Patients with Leukemia Undergoing Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT)Sana Khan, Morris Kletzel, Reggie Duerst et al.|Transplantation and Cellular Therapy|2016Cited by 0